de SauvageF.J., HassP.E., SpencerS.D.. Stimulation of megakaryocytopoiesis and thrombopoieses by the c-Mpl ligand.Nature1994; 369: 533–8.
2.
WachowiczB., KrajewskiT., OlasB., ZbikowskaH.M.. Effects of cisplatin and selenite on the level of thiols in pig blood platelets.J Physiol Pharmacol1995; 46: 97–103.
3.
WachowiczB.. Inhibitory effect of cisplatin on the enzymatic peroxidation of platelet endogenous arachidonate.Cytobios1993; 75: 157–62.
4.
TohyamaY., YanagiS., SadaK., YamamuraH.. Translocation of p72syk to the cytoskeleton in thrombin-stimulated platelets.J Biol Chem1994; 269: 32796–9.
5.
YanagiS., SadaK., TohyamaY.. Translocation, activation and association of protein-tyrosine kinase (p72syk) with phosphatidylinositol 3-kinase are early events during platelet activation.Eur J Biochem1994; 224: 329–33.
6.
WangX., SadaK., YanagiS.. Intracellular calcium dependent activation of p72syk in platelets.J Biochem (Tokyo)1994; 116: 858–61.
7.
DingK.H., LiangN.C.. inhibition of 5'-chloro-5'-deoxyadenosine on phosphoinositide and protein phosphorylation in swine platelets.Chung Kuo Yao Li Hsueh Pao1995; 16: 247–50.
8.
SchmaierA.H., DahlL.D., RosemullerA.J.. Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IX a.J Clin Invest1993; 92: 2540–5.
9.
EitzmanD.T., ChiL., SagginL.. Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.Circulation1994; 89: 1523–9.
10.
FujiiC., YanagiS., SadaK.. Involvement of protein-tyrosine kinase p72syk in collagen-induced signal transduction in platelet.Eur J Biochem1994; 226: 243–8.
11.
RezaulK., YanagiS., SadaK., TaniguchiT., YamamuraH.; Protein-tyrosine kinase p72syk is activated by platelet activating factor in platelets.Thromb Haemost1994; 72: 937–41.
12.
SadaK., YanagiS., YamamuraH.. Activation of p72syk by thrombin in a cell-free system.Biochem Biophys Res Commun1994; 200: 1–7.
13.
TaniguchiT., KitagawaH., YasueS.. Protein-tyrosine kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ mobilization in platelets.J Biol Chem1993; 268: 2277–9.
14.
BerthaB.G., SillJ.C., BergerI., FoltsJ.D., MildeJ.H.; High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.Anesthesiology1993; 78: 733–43.
15.
NarabaH., ImaiY., HayashiM., Oh-ishiS.. Enhanced production of platelet-activating factor in stimulated rat leukocytes caused by the blockade of lysophospholipid acylation.Jpn J Pharmacol1993; 61: 109–13.
16.
KaulS., PadgettR.C., HeistandD.D.. Role of platelets and leukocytes in modulation of vascular tone.Ann NY Acad Sci1994; 714: 122–35.
17.
BradburyA.W., MurieJ.A., RuckleyC.V.. Role of the leucocyte in the pathogenesis of vascular disease.Br J Surg1993; 80: 1503–12.
18.
MuylleL., PeetermansM.E.. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates.Vox Sang1994; 66: 14–7.
19.
KnightJ.A., SearlesD.A., BlaylockR.C.. Lipid peroxidation in platelet concentrates: effects of leukocyte removal by filtration.Ann Clin Lab Sci1994; 24: 69–75.
20.
KirchhoferD., TschoppT.B., HadvaryP., BaumgartnerH.R.. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.J Clin Invest1994; 93: 2073–83.
21.
KirchhoferD., SakariassenK.S., ClozelM.; Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions; Blood1993; 81: 2050–8.
22.
GrovesP.H., LewisM.J., CheadleH.A., PennyW.J.. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty.Circulation1993; 87: 590–7.
23.
KanwarS., WoodmanR.C., PoonM.C.. Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules.Blood1995; 86: 2760–6.
24.
LehrH.A., OlofssonA.M., CarewT.W.. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo.Lab Invest1994; 71: 380–6.
25.
GibsonR.M., KansasG.S., TedderT.F., FurieB., FurieB.C.. Lectin and epidermal growth factor domains of P-selectin at physiological density are the recognition unit for leukocyte binding.Blood1995; 85: 151–8.
26.
NagataK., TsujiT., HanaiN., IrimuraT.. Role of O-linked carbohydrate chains on leukocyte cell membranes in platelet-induced leukocyte activation.J Biol Chem1994; 269: 23290–5.
27.
GawazM., BognerC.. Changes in platelet membrane glycoproteins and platelet-leukocyte interaction during hemodialysis.Clin Invest1994; 72: 424–9.
28.
LuscherT.F.. Platelet-vessel wall interaction: role of nitric oxide, prostaglandins and endothelins.Baillieres Clin Haematol1993; 6: 609–27.
29.
YanZ., HoltJ.C., StewartG.J., NiewiarowskiS.. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.Am J Physiol1993; 265: C1396–404.
30.
PowerC.A., ProudfootA.E., MagnenatE., BaconK.B., WellsT.N.. Molecular cloning and characterization of a netrophil chemotactic protein from porcine platelets.Eur J Biochem1994; 221: 713–9.
31.
MatsumuraY., MurataS., TakadaK., TakaokaM., MorimotoS.; Involvement of transforming growth factor-beta 1 for platelets-induced stimulation of endothelin-1 production.Clin Exp Pharmacol Physiol1994; 21: 991–6.
32.
GrossD.R.. General principles of animal selection, preoperative care, preanesthesia, chemical restraint and analgesia. In: GrossD.R.. Animal models in cardiovascular research,2nd ed;Dordrecht/Boston/London: Kluwer Academic Publishers1994; 1–12.
33.
PondW.G.. Nutrition and the cardiovascular system of swine. In: StantonH.C., MersmannH.J.. Swine in cardiovascular research, Vol. II, Boca Raton: CRC Press1986; 2–31.
34.
DubickM.A., KilaniA.F., SummaryJ.J., GreeneJ.Y., WadeC.E.. Further evaluation of the effects of 7.5% sodium chloride/6% dextran-70 (HSD) administration on coagulation and platelet aggregation in hemorrhaged and euvolemic swine.Circ Shock1993; 40: 200–5.
35.
HessJ.R., DubickM.A., SummaryJ.J., BangalN.R., WadeC.E.. The effects of 7.5% NaCI/6% dextran 70 on coagulation and platelet aggregation in humans.J Trauma1992; 32: 40–4.
36.
BrandstetterH., BauerM., HuberR., LollarP., BodeW.. X-ray structure of clotting factor IX a: active site and module structure related to Xase activity and hemophilia B.Proc Natl Acad Sci USA1995; 92: 9796–800.
37.
HarveyR.B., KubenaL.F., ElissaldeM.H.. Influence of vitamin E on aflatoxicosis in growing swine.Am J Vet Res1994; 55: 572–7.
38.
BakkerC.M., BlankensteijnJ.D., SchlejenP.. The effects of long-term graft preservation on intraoperative hemostatic changes in liver transplantation. A comparison between orthotopic and heterotopic transplantation in the pig.HPB Surg1994; 7: 265–80.
39.
KargesH.E., FunkK.A., RonnebergeH.. Activity of coagulation and fibrinolysis parameters in animals.Arzneimittelforschung1994; 44: 793–7.
40.
LollarP., ParkerE.T., FayP.J.. Coagulant properties of hybrid human/porcine factor VIII molecules.J Biol Chem1992; 267: 23652–7.
41.
LubinI.M., HealeyJ.F., ScandellaD., RungeM.S., LollarP.; Elimination of a major inhibitor epitope in factor VIII.J Biol Chem1994; 269: 8639–41.
42.
CurtisJ.E., HelgersonS.L., ParkerE.T., LollarP.. Isolation and characterization of thrombin-activated human factor VIII.J Biol Chem1994; 269: 6246–51.
43.
MashikoH., TakahashiH.. Factor XI: purification from porcine plasma by affinity chromatography and some properties of factor XI and activated factor XI.Biol Chem Hopper Seyler1994; 375: 481–4.
44.
SchmaierA.H., DahlL.D., HasanA.A.. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes.Biochem1995; 34: 1171–8.
45.
AmC.M., CarageenJ.E., PlasmonR.R.. Mechanismbased isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substitutent in 7-amino-4-chloro-3-(isothiou-reidoalkoxy) isocoumarins on inhibitory and anticoagulant potency.J Med Chem1994; 37: 1298–306.
46.
SpannaglM., TraunerA., BirgA.. Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay.Blood Coagul Fibrinolysis1993; 4: 103–6.
47.
NicholsT.C., SamamaC.M., BellingerD.A.. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.Proc Natl Acad Sci USA1995; 92: 2455–9.
48.
FedericiA.B., MannucciP.M., FogatoE., GhidoniP., MatturrilL.. Autopsy findings in three patients with von Willebrand disease type MB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi.Thromb Haemost1993; 70: 758–61.
49.
SandersW.E.Jr., ReddickR.L., NicholsT.C., BrinkhousK.M., ReadM.S.; Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura.Arterioscler Thromb Vasc Biol1995; 15: 793–800.
50.
Radvanyi-HofmannH., RoussiJ., LaunaryJ.M.. Characterization of a thrombopathy (type delta storage pool disease) affecting a pig colony.Nouv Rev Fr Hematol1992; 34: 133–40.
51.
SchulzE., RuschitzkaF., LuedersS.. Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function.Kidney Int1995; 47: 795–801.
Apitz-CastroR., BadimonJ.J., BadimonL.. A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model.Thromb Res1994; 75: 243–9.
54.
UedaH., KobayashiT., KishimotoM., TsutsumiT., OkuyamaH.. EDTA-insensitive deacylation of phosphatidylinositol in porcine platelet membranes.Life Sci1993; 53: 629–34.
55.
PflieglerG., et-GamalB., BadimonJ.J., BadimonL., CrawfordN.. Inhibition of platelet recruitment to arterial lesions by predeposition of platelets containing encapsulated iloprost.Thromb Haemost1994; 72: 604–10.
56.
FletcherM.P., StahlG.L., LonghurstJ.C.. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.Am J Physiol1993; 265: H1750–61.
57.
SmithD.J., LaneT.A.. Effect of high concentration perflubron emulsion on platelet function.Biomater Artif Cells Immobvilization Biotechnol1993; 21: 173–81.
58.
ThibaudeauK., AnegonI., LemauffB., SoulillouJ.P., BlanchardD.. Human natural antibodies to porcine platelets.Transplantation1994; 57: 1110–5.
59.
GellerR.L., RubinsteinP., PlattJ.L.. Variation in expression of porcine xenogeneic antigens.Transplantation1994; 58: 272–7.
60.
ConnollyT.M., CondraC., FengD.M.. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.Thromb Haemost1994; 72: 627–33.
61.
WilbournB., HarrisonP., LawrieA.. Porcine platelets contain an increased quantity of ultra-high molecular weight von Willebrand factor and numerous alpha-granular tubular structures.Br J Haematol1993; 83: 608–15.
62.
RoussiJ., DrouetL., SigmaJ.. Absence of incorporation of plasma von Willebrand factor into porcine platelet alphagranules.Br J Haematol1995; 90: 661–8.
63.
DewanjeeM.K., KapadvanjwalaM., RuziusK.. Quantitation of thrombogenicity of hemodialyzer with technetium-99m and indium-111 labeled platelets.Nucl Med Biol1993; 20: 579–87.
64.
DewanjeeM.K., KapadvanjwalaM., MaoW.W.. A higher blood flow window of reduced thrombogenicity and acceptable fragmentation in a hollow fiber hemodialyzer.ASAIO J1993; 39: M363–7.
65.
DewanjeeM.K., KapadvanjwalaM., CavagnaroC.F.. In vitro and in vivo evaluation of the comparative thrombogenicity of cellulose acetate hemodialyzers with radio labeled platelets.ASAIO J1994; 40: 49–55.
QianK.X., WangS.S., ChuS.H.. Haematological variations in pigs during experimental left ventricular assistance with a pulsatile impeller pump.Med Eng Phys1994; 16: 348–50.
68.
ParssonH., JundzillW., HallbergE., ThorneJ., NorgrenL.. Acute thrombogenicity and 4 weeks healing properties of a new stretch-ePTFE graft.Eur J Vasc Surg1993; 7: 63–70.
69.
ScottN.A., NunesG.L., KingSB3rd, HarkerL.A., HansonS.R.. Local delivery of an antithrombin inhibits platelet-dependent thrombosis.Circulation1994; 90: 1951–5.
70.
NunesG.L., HansonS.R., KingSB3rd, SahatjianR.A., ScottN.A.. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis.J Am Coll Cardiol1994; 23: 1578–83.
71.
ParssonH., CwikielW., JohanssonK., SwartbolP., NorgrenL.. Depositiion of platelets and neutrophils in porcine iliac arteries after angioplasty and wallstent placement compared with angioplasty alone.Cardiovasc Intervent Radiol1994, 17: 190–6.
72.
BadimonJ.J., WengD., ChesebroJ.H., FusterV., BadimonL.. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.Thromb Haemost1994; 71: 511–6.
73.
MehriY., LacosteL.L., LamJ.Y.. Neutrophil implications in platelet deposition and vasoconstriction after deep arterial injury by angioplasty in pigs.Circulation1994; 90: 997–1002.
74.
MerhiY., LamJ.Y., LacosteL.L.. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces.Arterioscler Thromb1993; 13: 951–7.
75.
MeyerB.J., BadimonJ.J., MailhacA.. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy.Circulation1994; 90: 2432–8.
76.
MeyerB.J., Fernandez-OrtizA., MailhacA.. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.Circulation1994; 90: 2474–80.
77.
MoonD.G., MatayoshiB.M., WestonL.K., MinnearF.L., KaplanJ.E.. Fibronectin inhibition of platelet thrombus formation in an in vivo porcine model of vascular injury.Thromb Res1994; 76: 343–51.
78.
EitzmanD.T., ChiL., SagginL.. Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.Circulation1994; 89: 1523–9.
79.
NunesG.L., ThomasC.N., HansonS.R.. Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon.Circulation1995; 92: 1697–700.
80.
MailhacA., BadimonJ.J., FallonJ.T.. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis.Circulation1994; 90: 988–96.
81.
ScottN.A., RobinsonK.A., NunesG.L.. Comparison of the thrombogenicity of stainless steel and tantalum coronary stents.Am Heart J1995; 129: 866–72.
82.
StrattonJ.R., DewhurstT.A., KasinaS.. Selective uptake of radio labeled annexin V on acute porcine left atrial thrombi.Circulation1992; 92: 3113–21.
83.
TaitJ.F., CerqueiraM.D., DewhurstT.A.. Evaluation of annexin V as a platelet-directed thrombus targeting agent.Thromb Res1994; 75: 491–501.
84.
TaitJ.F., EngelhardtS., SmithC., FujikawaK.. Prourokinaseannexin V chimeras. Construction, expression and characterization of recombinant proteins.J Biol Chem1995; 270: 21594–9.
85.
JohnsonC.M., BowieE.J.. Pigs with von Willebrand disease may be resistant to experimental infective endocarditis.J Lab Clin Med1992; 120: 553–8.
86.
ZoldhelyiP., ChesebroJ.H., OwenW.G.. Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig.Proc Natl Acad Sci USA1993; 90: 1819–23.
87.
WalpothB.H., AmmonA., GaldikasJ.. Experimental assessment of thrombogenicity in vascular prostheses before and during prostaglandin E1 treatment.Eur J Vasc Surg1993; 7: 493–9.
88.
ThompsonJ.F., BellR., BookallilM.J., SheilA.G.. Effects of total hepatectomy: studies in a porcine model.Aust N Z J Surg1994; 64: 560–4.
89.
MalmrosC., BolmquistS., MartenssonL., ThorneJ.. Iloprost attenuates trauma-related pulmonary sequestration of leucocytes and platelets.Prostaglandins Leukot Essent Fatty Acids1994; 50: 203–10.